Detailed price information for Rapport Therapeutics Inc (RAPP-Q) from The Globe and Mail including charting and trades.

Teacher Yareli Jessica Gijon tells PEOPLE how she manages epilepsy in the classroom and why she posted a seizure video to ...

Drug-resistant epilepsy affects millions of people worldwide and remains one of the most difficult neurological disorders to treat. For patients whose seizures continue despite medication, surgical ...

Abstract: In this work, we propose a novel hybrid architecture for epileptic seizure prediction, utilizing a deep learning approach by stacking the convolutional neural network (CNN) and bidirectional ...

Bristol Myers Squibb's big buys: $18.1 billion in 2 biotech deals Xenon Pharmaceuticals (NASDAQ:XENE) said it is preparing to ...

Angelini Pharma is acquiring Catalyst Pharmaceuticals in a $4.1 billion transaction that expands its presence in the US rare ...

Reported positive topline data from Phase 3 X-TOLE2 study of azetukalner in FOS in March and anticipate NDA submission in Q3 2026Five additional Phase 3 studies of azetukalner continue to enroll in ep ...

Focal Bathys MG delivers top-tier wireless sound with upgraded ANC, premium comfort, and detail but at $1,499, rivals like Sony, Bowers & Wilkins, and DALI push hard. I said it on our 100th podcast: ...

Reported positive topline data from Phase 3 X-TOLE2 study of azetukalner in FOS in March and anticipate NDA submission in Q3 2026Five additional ...

Consideration is set at $31.50 per Catalyst share in cash, implying an equity value above $4.1 billion and a 21% premium to ...

Epilepsy is a neurological disorder that causes temporary brain dysfunction. The aftermath of an epileptic seizure varies for each individual and depends on its severity. FITBOOK outlines types of ...

NeuroPace, Inc. , a medical device company focused on transforming the lives of people living with drug resistant epilepsy, today announced a major milestone in its clinical evidence program with the ...